Antiarrhythmic Drugs
Question 1. Enumerate Antiarrhythmic Drugs. Discuss Their Mechanisms And Therapeutic Uses.
Answer:
Enumeration Of Antiarrhythmic Drugs
- Class I: Sodium channel blocker
- Ia: Quinidine, procainamide, disopyramide
- Ib: Lignocaine, mexiletine, phenytoin
- Ic: Flecainide and propafenone.
- Class II: β-blockers, i.e. propranolol
- Class III: Drugs widening atrial pressure, i.e. bretylium
- Class IV: Calcium channel blockers, i.e. nifedipine, verapamil.
Read And Learn More: Pharmacology Question And Answers
Mechanism Of Antiarrhythmic Drugs
- Antiarrhythmic drugs act by blocking sodium, calcium, and potassium channels.
- The subclass Ia, antiarrhythmic drugs decrease impulse generation and stop abnormal impulse generation.
- Subclass Ib drugs block sodium channels in both activated and inactivated states.
- Subclass Ic, drugs are the most potent sodium channel blockers with more prominent action open state and longest recovery times. They have a variable effect on action potential duration.
- Class II drugs, i.e. β blockers suppress adrenergically mediated ectopic activity.
- Class III drugs increase repolarization. Generally, the potassium channel causes a prolongation of repolarization.
- Class IV drugs are used in paroxysmal supraventricular tachycardia, they slow down SA node and suppress AV conduction.
Therapeutic Uses Of Antiarrhythmic Drugs
- Subclass I, drugs prevent ventricular arrhythmias.
- The subclass Ib drugs are used in arrhythmias following myocardial infarction and cardiac surgery. The drugs are also used in digitalis toxicity.
- Subclass Ic drugs are potent sodium channel blockers. They maintain sinus rhythm in atrial fibrillation.
- Class II drugs are useful in atrial or nodal extrasystole due to emotion/stress.
- Class II drugs are also helpful in digitalis-induced and postmyocardial infarction arrhythmias.
- Class Ill drugs are used in ventricular tachycardia and ventricular fibrillation.
- Class IV drugs are used in paroxysmal supraventricular tachycardia and AV block.
Leave a Reply